Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible?
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. M. Verleden, L. J. Dupont, B. M. Vanaudenaerde, D. E. Van Raemdonck (Leuven, Belgium). Does colonization with pseudomonas affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation?. Eur Respir J 2006; 28: Suppl. 50, 774

Member's Comments

No comment yet.

Related content which might interest you: Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation? Source: Eur Respir J 2008; 31: 1037-1045 Year: 2008 Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 177s Year: 2004 A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008 Infection and bronchiolitis obliterans syndrome in lung transplant recipients Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44 Year: 2004 Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure? Source: Eur Respir J 2011; 37: 10-12 Year: 2011 Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004 Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Source: Eur Respir J 2005; 25: 221-224 Year: 2005 A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011 Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003 Current status of lung transplantation Source: Eur Respir J 2003; 22: 57S-64S Year: 2003 Incidence and risk factors for bronchiolitis obliterans syndrome stage 0p after lung transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome Source: Eur Respir J 2008; 32: 670-677 Year: 2008 Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19 Year: 2004 Post-transplant bronchiolitis obliterans Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=158 Year: 2003 Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans Source: Eur Respir J 2004; 23: 384-390 Year: 2004 Pseudomonas aeruginosa accentuates epithelial-to-mesenchymal transition in the airway Source: Eur Respir J 2011; 37: 1237-1247 Year: 2011 Bronchiolitis obliterans syndrome and bronchiolitis obliterans in lung transplantation: will a pathologist and a physician ever meet? Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=55 Year: 2004 Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation. Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings Year: 2018 Postinfection bronchiolitis obliterans in structure of chronic lung diseases in children Source: Eur Respir J 2005; 26: Suppl. 49, 29s Year: 2005 Bronchiectasis as prognostic factor in bronchiolitis obliterans syndrome after lung transplantation Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction Year: 2018